Wutah dodolan YoY sajrone 12 wulan kepungkur: bionanogenomics.com (BNGO)

Bionano Genomics, Inc. (BNGO) holds a monopoly thanks to its Saphyr system for DNA analysis. The primary focus is on robotic optical mapping complexes, which completely eliminate routine laboratory labor during sample preparation. The year-over-year (12-month) relative revenue growth rate confirms the expansion trend, with the value stabilizing at 8.40. Growth is constrained only by the limited budgets of medical institutions.
Bionano Genomics, Inc. (BNGO) - rincian metrik lan laporan keuangan

Investors are assessing the potential of Bionano Genomics, Inc. (BNGO) through revenue scaling dynamics, where the calculated percentage change in total sales over the last four quarters relative to the previous year reveals the actual pace of business expansion. By analyzing the annual revenue growth rate over a rolling four-quarter period, one can determine how effectively Saphyr system patents are being converted into market share, overcoming the technological barrier in the field of optical genome mapping.